WISP3-IGF1 interaction regulates chondrocyte hypertrophy

Journal of Cell Science

Volumn 126, Issue 7, 2013, Pages 1650-1658

  Repudi, Srinivasa Rao ^a   Patra, Milan ^a   Sen, Malini ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Hypertrophy; IGF1; WISP3

Indexed keywords

ALKALINE PHOSPHATASE; CELL PROTEIN; COLLAGEN TYPE 10; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; WNT INDUCED SECRETED PROTEIN 3;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

HYPERTROPHY; IGF1; WISP3;

CCN INTERCELLULAR SIGNALING PROTEINS; CELL ENLARGEMENT; CELL LINE; CHONDROCYTES; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; PROTEIN BINDING; REACTIVE OXYGEN SPECIES;

EID: 84877992436     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.119859     Document Type: Article

References (56)

1. Aszodi, A., Hunziker, E. B., Brakebusch, C. and Fässler,R. (2003). Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev. 17, 2465-2479.
2. Atsumi, T., Miwa, Y., Kimata, K. and Ikawa, Y. (1990). A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30, 109-116.
3. Baker, N., Sharpe, P., Culley, K., Otero, M., Bevan, D., Newham, P., Barker, W., Clements, K. M., Langham, C. J., Goldring, M. B. et al. (2012). Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6. Arthritis Rheum. 64, 2289-2299.
4. Bernstine, E. G., Hooper, M. L., Grandchamp, S. and Ephrussi, B. (1973). Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. USA 70, 3899-3903.
5. Böhme, K., Conscience-Egli, M., Tschan, T., Winterhalter, K. H. and Bruckner, P. (1992). Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine. J. Cell Biol. 116, 1035-1042.
6. Burren, C. P., Wilson, E. M., Hwa, V., Oh, Y. and Rosenfeld, R. G. (1999). Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J. Clin. Endocrinol. Metab. 84, 1096-1103.
7. Chand, H. S., Harris, J. F., Mebratu, Y., Chen, Y., Wright, P. S., Randell, S. H. and Tesfaigzi, Y. (2012). Intracellular insulin-like growth factor-1 induces Bcl-2 expression in airway epithelial cells. J. Immunol. 188, 4581-4589.
8. Cui, R. R., Huang, J., Yi, L., Xie, H., Zhou, H. D., Yuan, L. Q., Wang, M., Peng, Y. Q., Luo, X. H. and Liao, E. Y. (2007). WISP3 suppresses insulin-like growth factor signaling in human chondrocytes. Mol. Cell. Endocrinol. 279, 1-8.
9. Davis, L., Chen, Y. and Sen, M. (2006). WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem. Biophys. Res. Commun. 342, 259-265.
10. Delague, V., Chouery, E., Corbani, S., Ghanem, I., Aamar, S., Fischer, J., Levy-Lahad, E., Urtizberea, J. A. and Mégarbané, A. (2005). Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect. Am. J. Med. Genet. 138A, 118-126.
11. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
12. Fujita, T., Azuma, Y., Fukuyama, R., Hattori, Y., Yoshida, C., Koida, M., Ogita, K. and Komori, T. (2004). Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol. 166, 85-95.
13. Garcia Segarra, N., Mittaz, L., Campos-Xavier, A. B., Bartels, C. F., Tuysuz, B., Alanay, Y., Cimaz, R., Cormier-Daire, V., Di Rocco, M., Duba, H. C. et al. (2012). The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am. J. Med. Genet. 160C, 217-229.
14. Goldring, M. B., Birkhead, J. R., Suen, L. F., Yamin, R., Mizuno, S., Glowacki, J., Arbiser, J. L. and Apperley, J. F. (1994). Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94, 2307-2316.
15. Grotendorst, G. R., Lau, L. F. and Perbal, B. (2000). CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology 141, 2254-2256.
16. Hirsch, M. S., Lunsford, L. E., Trinkaus-Randall, V. and Svoboda, K. K. (1997). Chondrocyte survival and differentiation in situ are integrin mediated. Dev. Dyn. 210, 249-263.
17. Holbourn, K. P., Acharya, K. R. and Perbal, B. (2008). The CCN family of proteins: structure-function relationships. Trends Biochem. Sci. 33, 461-473.
18. Hurvitz, J. R., Suwairi, W. M., Van Hul, W., El-Shanti, H., Superti-Furga, A., Roudier, J., Holderbaum, D., Pauli, R. M., Herd, J. K., Van Hul, E. V. et al. (1999). Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23, 94-98.
19. Iwasaki, K., Komaki, M., Mimori, K., Leon, E., Izumi, Y. and Ishikawa, I. (2008). IL-6 induces osteoblastic differentiation of periodontal ligament cells. J. Dent. Res. 87, 937-942.
20. Katsube, K., Sakamoto, K., Tamamura, Y. and Yamaguchi, A. (2009). Role of CCN, a vertebrate specific gene family, in development. Dev. Growth Differ. 51, 55-67.
21. Katsuki, Y., Sakamoto, K., Minamizato, T., Makino, H., Umezawa, A., Ikeda, M. A., Perbal, B., Amagasa, T., Yamaguchi, A. and Katsube, K. (2008). Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1. Biochem. Biophys. Res. Commun. 368, 808-814.
22. Kim, H. S., Nagalla, S. R., Oh, Y., Wilson, E., Roberts, C. T., Jr and Rosenfeld, R. G. (1997). Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA 94, 12981-12986.
23. Kim, K. S., Choi, H. W., Yoon, H. E. and Kim, I. Y. (2010). Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation. J. Biol. Chem. 285, 40294-40302.
24. Kim, H. R., Heo, Y. M., Jeong, K. I., Kim, Y. M., Jang, H. L., Lee, K. Y., Yeo, C. Y., Kim, S. H., Lee, H. K., Kim, S. R. et al. (2012). FGF-2 inhibits TNF-a mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells. BMB Rep. 45, 287-292.
25. Kleer, C. G., Zhang, Y., Pan, Q. and Merajver, S. D. (2004). WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6, 179-185.
26. Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336.
27. Lamb, R., Thomson, W., Ogilvie, E. and Donn, R. (2005). The British Society of Paediatric and Adolescent Rheumatology. Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum. 52, 3548-3553.
28. Lee, G. Y., Kenny, P. A., Lee, E. H. and Bissell, M. J. (2007). Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4, 359-365.
29. Lorenzatti, G., Huang, W., Pal, A., Cabanillas, A. M. and Kleer, C. G. (2011). CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J. Cell Sci. 124, 1752-1758.
30. McComb, R. B. and Bowers, G. N., Jr (1972). Study of optimum buffer conditions for measuring alkaline phosphatase activity in human serum. Clin. Chem. 18, 97-104.
31. McDonald, N. Q. and Hendrickson, W. A. (1993). A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424.
32. McQuillan, D. J., Handley, C. J., Campbell, M. A., Bolis, S., Milway, V. E. and Herington, A. C. (1986). Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem. J. 240, 423-430.
33. Meng, D., Shi, X., Jiang, B. H. and Fang, J. (2007). Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 42, 1651-1660.
34. Miller, D. S. and Sen, M. (2007). Potential role of WISP3 (CCN6) in regulating the accumulation of reactive oxygen species. Biochem. Biophys. Res. Commun. 355, 156-161.
35. Mireuta, M., Hancock, M. A. and Pollak, M. (2011). Binding between insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 is not influenced by glucose or 2-deoxy-D-glucose. J. Biol. Chem. 286, 16567-16573.
36. Morita, K., Miyamoto, T., Fujita, N., Kubota, Y., Ito, K., Takubo, K., Miyamoto, K., Ninomiya, K., Suzuki, T., Iwasaki, R. et al. (2007). Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification. J. Exp. Med. 204, 1613-1623.
37. Moussad, E. E. and Brigstock, D. R. (2000). Connective tissue growth factor: what's in a name? Mol. Genet. Metab. 71, 276-292.
38. Mueller, M. B. and Tuan, R. S. (2008). Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum. 58, 1377-1388.
39. Nakamura, Y., Weidinger, G., Liang, J. O., Aquilina-Beck, A., Tamai, K., Moon, R. T. and Warman, M. L. (2007). The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J. Clin. Invest. 117, 3075-3086.
40. Nixon, A. J., Saxer, R. A. and Brower-Toland, B. D. (2001). Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes. J. Orthop. Res. 19, 26-32.
41. Ohlsson, C., Nilsson, A., Isaksson, O. G. and Lindahl, A. (1992). Effect of growth hormone and insulin-like growth factor-I on DNA synthesis and matrix production in rat epiphyseal chondrocytes in monolayer culture. J. Endocrinol. 133, 291-300.
42. Ono, M., Inkson, C. A., Kilts, T. M. and Young, M. F. (2011). WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J. Bone Miner. Res. 26, 193-208.
43. Pal, A., Huang, W., Li, X., Toy, K. A., Nikolovska-Coleska, Z. and Kleer, C. G. (2012). CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res. 72, 4818-4828.
44. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M. et al. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95, 14717-14722.
45. Perbal, B. (2001). NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol. 54, 57-79.
46. Philippou, A., Maridaki, M., Halapas, A. and Koutsilieris, M. (2007). The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 21, 45-54.
47. Qiao, M., Shapiro, P., Kumar, R. and Passaniti, A. (2004). Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J. Biol. Chem. 279, 42709-42718.
48. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C. and Jakob, F. (2005). Differential expression of CCN-family members in primary human bone marrowderived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun. Signal. 3, 5.
49. Seki, K., Fujimori, T., Savagner, P., Hata, A., Aikawa, T., Ogata, N., Nabeshima, Y. and Kaechoong, L. (2003). Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. J. Biol. Chem. 278, 41862-41870.
50. Sen, M., Cheng, Y. H., Goldring, M. B., Lotz, M. K. and Carson, D. A. (2004). WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum. 50, 488-497.
51. Stephens, M., Kwan, A. P., Bayliss, M. T. and Archer, C. W. (1992). Human articular surface chondrocytes initiate alkaline phosphatase and type X collagen synthesis in suspension culture. J. Cell Sci. 103, 1111-1116.
52. Takigawa, M., Nakanishi, T., Kubota, S. and Nishida, T. (2003). Role of CTGF/ HCS24/ecogenin in skeletal growth control. J. Cell. Physiol. 194, 256-266.
53. Tanaka, K., Yokosaki, Y., Higashikawa, F., Saito, Y., Eboshida, A. and Ochi, M. (2007). The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol. 26, 409-418.
54. Wang, J., Zhou, J. and Bondy, C. A. (1999). Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J. 13, 1985-1990.
55. Wu, S., Fadoju, D., Rezvani, G. and De Luca, F. (2008). Stimulatory effects of insulinlike growth factor-I on growth plate chondrogenesis are mediated by nuclear factorkappaB p65. J. Biol. Chem. 283, 34037-34044.
56. Zheng, Q., Zhou, G., Morello, R., Chen, Y., Garcia-Rojas, X. and Lee, B. (2003). Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 162, 833-842.